Indivior Pharmaceuticals, Inc. INDV Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Indivior Pharmaceuticals, Inc. ’s reported figures.
Based on trailing twelve months.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's interest coverage?
- Indivior Pharmaceuticals, Inc. (INDV) reported interest coverage of 8.3× in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's interest coverage changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's interest coverage increased by 1191.9% year-over-year, from 0.6× to 8.3×.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's interest coverage?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's interest coverage has grown at a 26.9% compound annual growth rate (CAGR), from -2.9× to 5.8×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.